The Quinidine Sulfate Capsules, cataloged under National Stock Number 6505-00-564-7320, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Solvay Pharmaceuticals, Inc.. Government technical data includes 7 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-00-564-7320 |
| Primary Part Number | NDC00032-4020-05 |
| Item Name | Quinidine Sulfate Capsules |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Solvay Pharmaceuticals, Inc. |
| Status | ACTIVE |
| Therapeutic Equivalent | ANY A RATED DRUG |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Capsule Primary Container Content Quantity | 500.000 |
| Capsule Type | HARD |
| Capsule Content Form | POWDER |
| Active Medicament Medicinal Strength | 300.000 MILLIGRAMS QUINIDINE SULFATE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC00032-4020-05 PRIMARY | Solvay Pharmaceuticals, Inc. (USA) |
| Reference | Meaning |
|---|---|
| CIN-QUIN 300 | 5/1 Secondary reference Solvay Pharmaceuticals, Inc. |
| NDC00781-2997-05 | 5/9 Secondary reference Geneva Pharmaceuticals Inc |
NSN 6505-00-564-7320 is a Quinidine Sulfate Capsules, manufactured by Solvay Pharmaceuticals, Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-00-564-7320 has 1 manufacturer part number on file: NDC00032-4020-05 (Solvay Pharmaceuticals, Inc.).
Key specifications for NDC00032-4020-05: Therapeutic Equivalent: ANY A RATED DRUG; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Capsule Primary Container Content Quantity: 500.000. 7 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.